Paradigm Biopharmaceuticals Ltd.ASX: PAR

First Participant Dosed in PARs Phase 2b OA Clinical Trial

Oct 30, 2017 at 2:00 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment